Kyber, first observed in circulation as early as September, takes its name from the alternate designation of ML-KEM ...
A relatively new ransomware family is using a novel approach to hype the strength of the encryption used to scramble ...
Moonshot AI today released Kimi-K2.6, the latest addition to its popular Kimi series of open-source large language models.
Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...
Good Monday morning in New York City, where the kids are complaining that their student OMNY cards are too flimsy. This was the same site where Councilmember Susan Zhuang was arrested in 2024 for ...
Google published a research blog post on Tuesday about a new compression algorithm for AI models. Within hours, memory stocks were falling. Micron dropped 3 per cent, Western Digital lost 4.7 per cent ...
Abstract: In computational metabolic design, it is often necessary to modify the original constraint-based metabolic networks to lead to growth-coupled production, where cell growth forces target ...
Colson Montgomery's launch angle consistency bodes well for his ability to improve his batting average returns. Icon Sportswire / Getty Images Diving into the standard deviation of launch angle (sdLA) ...
Organizations of all sizes in all industries face a monumental project of migrating to post-quantum cryptography (PQC) to address the risk of adversaries using quantum computing to intercept sensitive ...
Meta has now rolled out the "Build Your 2026 Algorithm" feature for Instagram Reels to allow users use it to personalize their feeds. Instagram Reels 'Build Your 2026 Algorithm' Now Live After a test ...
Google on Sunday announced a new open standard called the Universal Commerce Protocol (UCP) for AI agent-based shopping, at the National Retail Federation (NRF) conference. The standard, developed ...
Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...